Cross Country Healthcare (NASDAQ:CCRN) Price Target Lowered to $19.00 at Benchmark

Cross Country Healthcare (NASDAQ:CCRNFree Report) had its price objective trimmed by Benchmark from $21.00 to $19.00 in a research report released on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the business services provider’s stock.

A number of other research analysts have also recently weighed in on CCRN. TheStreet cut shares of Cross Country Healthcare from a b- rating to a c+ rating in a research report on Friday, March 1st. Barrington Research cut their target price on Cross Country Healthcare from $26.00 to $24.00 and set an outperform rating on the stock in a research note on Tuesday, February 27th. Finally, Truist Financial decreased their price target on Cross Country Healthcare from $22.00 to $16.00 and set a hold rating for the company in a research note on Thursday, February 22nd. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Cross Country Healthcare currently has an average rating of Hold and a consensus target price of $21.33.

Check Out Our Latest Stock Report on CCRN

Cross Country Healthcare Trading Down 0.4 %

CCRN traded down $0.07 during trading hours on Thursday, hitting $16.67. The company’s stock had a trading volume of 553,081 shares, compared to its average volume of 287,450. The stock has a market cap of $578.12 million, a price-to-earnings ratio of 12.82, a P/E/G ratio of 1.85 and a beta of 0.77. The business’s 50-day moving average price is $17.92 and its 200-day moving average price is $20.03. Cross Country Healthcare has a 12 month low of $15.65 and a 12 month high of $28.75.

Cross Country Healthcare (NASDAQ:CCRNGet Free Report) last issued its quarterly earnings data on Wednesday, May 1st. The business services provider reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The business had revenue of $379.17 million during the quarter, compared to analysts’ expectations of $374.38 million. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. The business’s revenue was down 39.1% on a year-over-year basis. During the same period last year, the company posted $0.84 EPS. On average, analysts forecast that Cross Country Healthcare will post 0.9 earnings per share for the current year.

Insider Buying and Selling

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $16.95, for a total transaction of $105,361.20. Following the transaction, the insider now owns 35,101 shares of the company’s stock, valued at approximately $594,961.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. SG Americas Securities LLC purchased a new stake in shares of Cross Country Healthcare during the third quarter valued at about $453,000. Raymond James & Associates acquired a new position in shares of Cross Country Healthcare during the third quarter worth $2,097,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Cross Country Healthcare by 305.8% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,570 shares of the business services provider’s stock valued at $584,000 after purchasing an additional 17,762 shares during the last quarter. TD Asset Management Inc boosted its position in shares of Cross Country Healthcare by 87.0% in the 3rd quarter. TD Asset Management Inc now owns 14,400 shares of the business services provider’s stock worth $357,000 after purchasing an additional 6,700 shares in the last quarter. Finally, Paradiem LLC grew its stake in Cross Country Healthcare by 5.0% during the 3rd quarter. Paradiem LLC now owns 131,989 shares of the business services provider’s stock worth $3,272,000 after buying an additional 6,341 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Articles

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.